Published in Cancer Weekly, January 27th, 2009
"Recent studies indicate that CYLD is a tumour-suppressor gene. The CYLD protein is a negative regulator of the activation of transcription factor nuclear factor-kappa B, and loss of CYLD contributes to oncogenesis," wrote T.M. Huang and colleagues, National Cheng-Kung University, Medical Department.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.